New York, United States, April 29, 2026 /MarketersMEDIA/ -- Amerigo Scientific, a trusted provider of critical reagents and assay solutions for life science research, released its expanded portfolio ...

NanoMosaic, Inc., a leader in advanced analytical technologies for cell and gene therapy development and manufacturing, today announced its strong scientific and commercial presence at the American ...

AAX Biotech has partnered with evitria AG to expand access to its Opti-mAb® platform, enabling earlier integration of ...

Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic ...

Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.

Veterans of the autonomous vehicle industry who founded their own robotics outfit told BI that AV experience has a lot of ...

Affinia Therapeutics ("Affinia"), an innovative gene therapy company with a pipeline of first-in-class and/or best-in-class adeno-associated virus (AAV) gene therapies initially for devastating ...

Opinion: As AI use becomes more frequent in the invention of new drugs, it’s important to determine how it affects who’s ...

In vitro data demonstratedself-complementary AAV9 (scAAV9) enabled ~30-fold higher MeCP2 protein expression compared to single-stranded AAV9 ...

AviadoBio will combine its proprietary vMiX™ RNAi platform with Apertura’s novel human TfR1 capsid (TfR1 CapX™) to enable one-time gene silencing in the central nervous system AviadoBio will present k ...

Learn how early coordination across functions, phases and partners can reduce risk and accelerate drug development.

Ametefgene parvec (AB-1005) manufactured at Viralgen commercial manufacturing facility with next-generation process to deliver high-purity product with greater efficiency   AskBio Inc. (AskBio), a ...